APP and Alzheimer disease: On the other hand, increased Hsp70 has been found to mitigate AD hallmarks by interacting with APP, disrupting its secretory pathway, thereby reducing Aβ formation (Hoshino et al. 2011) and aggregation (Maiti et al. 2014).